BIOL

Biolase (BIOL)

Biolase Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BIOL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/18	19 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/06/04	06 : 17	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BIOL	Biolase Inc
2024/05/17	19 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/05/17	19 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/05/17	19 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/05/17	19 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/05/14	05 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIOL	Biolase Inc
2024/05/14	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/05/07	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/03/08	20 : 31	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BIOL	Biolase Inc
2024/03/05	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/28	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/24	06 : 05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BIOL	Biolase Inc
2024/02/22	06 : 39	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BIOL	Biolase Inc
2024/02/21	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/16	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/15	03 : 10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/14	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIOL	Biolase Inc
2024/02/14	10 : 03	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/09	22 : 44	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/07	20 : 11	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/07	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/01/31	11 : 57	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/01/30	07 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/01/29	20 : 30	PR Newswire (US)	BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	NASDAQ:BIOL	Biolase Inc
2024/01/25	07 : 21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BIOL	Biolase Inc
2024/01/19	20 : 09	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BIOL	Biolase Inc
2024/01/09	06 : 05	PR Newswire (US)	BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023	NASDAQ:BIOL	Biolase Inc
2024/01/04	06 : 05	PR Newswire (US)	BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD	NASDAQ:BIOL	Biolase Inc
2023/12/30	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc